KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Inventory Average (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Inventory Average for 12 consecutive years, with $5.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average fell 9.02% year-over-year to $5.7 million, compared with a TTM value of $5.7 million through Dec 2025, down 9.02%, and an annual FY2025 reading of $6.0 million, down 22.65% over the prior year.
  • Inventory Average was $5.7 million for Q4 2025 at Travere Therapeutics, up from $4.8 million in the prior quarter.
  • Across five years, Inventory Average topped out at $19.8 million in Q3 2023 and bottomed at $4.0 million in Q2 2025.
  • Average Inventory Average over 5 years is $7.7 million, with a median of $6.9 million recorded in 2021.
  • The sharpest move saw Inventory Average skyrocketed 164.84% in 2023, then tumbled 68.81% in 2024.
  • Year by year, Inventory Average stood at $7.0 million in 2021, then dropped by 15.14% to $5.9 million in 2022, then soared by 155.36% to $15.1 million in 2023, then tumbled by 58.4% to $6.3 million in 2024, then decreased by 9.02% to $5.7 million in 2025.
  • Business Quant data shows Inventory Average for TVTX at $5.7 million in Q4 2025, $4.8 million in Q3 2025, and $4.0 million in Q2 2025.